Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Clobetasol 0.05% Oral Rinse for Oral Chronic Graft-Versus-Host-Disease
NCT01557517Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2012
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clobetasol in chronic graft-versus-host disease (cGVHD), sponsored by National Cancer Institute. Started Mar 2012; status: completed.
02
Drugs
clobetasol
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01557517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01557517.